A French approach to cost-effectiveness analysis?
Gérard
G
de Pouvourville
D003324:Coronary Artery Disease / Q000188:drug therapy / Q000191:economics; D003362:Cost-Benefit Analysis / Q000191:economics; D017598:Efficiency, Organizational; D005602:France; D017048:Health Care Costs / Q000706:statistics & numerical data*; D005102:Health Expenditures / Q000706:statistics & numerical data*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics / Q000627:therapeutic use; D007349:Insurance, Health, Reimbursement / Q000191:economics* / Q000706:statistics & numerical data
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors